Which statement is not described as part of the Investigator's Brochure's purpose?

Which statement is not described as part of the Investigator's Brochure's purpose?

• A. Providing information to facilitate risk-benefit assessment
• B. Providing concise and non-promotional information
• C. Supporting the clinical management of trial subjects
• D. Discussing marketing strategies for the product

Answer: (D)

The main idea is that the Investigator’s Brochure (IB) is a regulatory document that provides investigators with comprehensive, factual, and non-promotional information about the investigational product to support safe and effective trial conduct. It consolidates pharmacology, pharmacokinetics, toxicology, prior and current clinical data, and safety information so clinicians can make informed risk-benefit judgments and manage trial subjects appropriately. It offers guidance for dosing, monitoring, and handling adverse events, ensuring investigators understand how to protect participants and detect safety signals early. A key requirement is that the content remains concise and non-promotional. Marketing strategies, on the other hand, are outside the scope of the IB. The document is not a marketing or promotional tool; its purpose is to inform trial conduct and subject safety, not to promote the product.

The main idea is that the Investigator’s Brochure (IB) is a regulatory document that provides investigators with comprehensive, factual, and non-promotional information about the investigational product to support safe and effective trial conduct. It consolidates pharmacology, pharmacokinetics, toxicology, prior and current clinical data, and safety information so clinicians can make informed risk-benefit judgments and manage trial subjects appropriately. It offers guidance for dosing, monitoring, and handling adverse events, ensuring investigators understand how to protect participants and detect safety signals early. A key requirement is that the content remains concise and non-promotional.

Marketing strategies, on the other hand, are outside the scope of the IB. The document is not a marketing or promotional tool; its purpose is to inform trial conduct and subject safety, not to promote the product.